I Holland to hold webinar on how to overcome tabletting challenges
Company will discuss common tabletting problems such as increasing output without capital expenditure, eliminating sticking and abrasion, minimising headwear and corrosion, all of which can be done through innovative means.
I Holland will host a webinar entitled ‘How to solve tabletting problems with innovative solutions’ on 29 September 2016, as part of its 70th anniversary celebrations.
Aimed for the tablet compression industry including pharmaceutical, nutraceutical, veterinary, confectionary and industrial sectors, the webinar seeks to provide helpful information and tips for those looking for new innovative solutions to everyday problems.
During the webinar, I Holland will discuss common tabletting problems such as increasing output without capital expenditure, eliminating sticking and abrasion, minimising headwear and corrosion, all of which can be done through innovative means. Tablet manufacturers are increasingly required to overcome and eliminate these problems with minimal investment to ensure a better quality end product providing direct cost savings and optimised productivity.
The first of this series of three webinars, entitled ‘Improve production efficiency from tablet design to tool maintenance and specification’, took place on 12 May 2016. Delivering structured advice to the tablet manufacturing industries, the webinar centred on how efficiency in solid dose manufacturing can be improved at the earliest stages of the tablet design process by utilising precise tooling specifications and can still be viewed on demand from I Holland’s website.
As 2016 signifies I Holland’s 70th anniversary in equipping its partners with affordable high quality tooling and technical support service and information, the webinars showcase the tabletting expert’s knowledge in choosing and optimising tablet design and tool material selection, features and configuration and tooling maintenance and life-cycle management.
“Webinars are a really easy and efficient way to explore common problems within the tablet manufacturing industry and share knowledge with our industry peers. We find that the interactive question and answer element of the session enable our prospective and existing partners to ask further questions and express common ideas and experiences,” says Alex Bunting, Marketing Manager, I Holland.
Related News
-
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Pharma Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain. -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement. -
News BIOSECURE Act continues to loom over Chinese pharma manufacturers
With the US BIOSECURE Act on its way to passing into legislation, Chinese companies are facing declining revenues within the first half of 2024 as US pharmaceutical and healthcare companies pull their businesses from the country. -
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance